WaferGen Bio-Systems (WGBS) Announces Presentation of ICELL8 Single-Cell System TCR Results
- Tritium DCFC Limited (DCFC): Three Australian subsidiaries were determined to be insolvent or likely to become insolvent
- Hasbro (HAS) Announces Resignation of Cynthia Williams, President of Wizards of the Coast and Hasbro Gaming
- Frontier Communications (FYBR) says third party had gained unauthorized access to portions of its information technology environment
- Ibotta (IBTA) Prices 6.56M Share IPO at $88/sh
- Netflix (NFLX) Tops Q1 EPS by 77c, Offers Guidance
- After-hours movers: Netflix, Intuitive Surgical, Nordstrom, KB Home
- Midday movers: Tesla, Blackstone, Las Vegas Sands fall; DR Horton rises
- After-hours movers: Alcoa rises; Equifax and Las Vegas Sands fall
- Midday movers: Travelers, JB Hunt fall; United Airlines rises
- After-hours movers: United Airlines, J.B. Hunt, and more
WaferGen Presents Single-Cell T-Cell Receptor Sequencing Results Using the ICELL8™ Single-Cell System at the 2016 Single Cell Genomics Meeting
September 14, 2016 8:02 AM EDTFREMONT, Calif., Sept. 14, 2016 /PRNewswire/ -- WaferGen Bio-systems, Inc. (Nasdaq: WGBS) presented T-cell receptor (TCR) sequencing results from its ICELL8 Single-Cell System at the Single Cell Genomics Conference in Cambridge, United Kingdom. The poster presentation, titled "A SMARTer® Approach to Profiling the Human T-cell Receptor Repertoire Using the ICELL8 Single Cell System", demonstrates the ability to perform TCR sequencing from thousands of single cells and is a joint poster with Takara Bio USA, Inc. (formerly known as Clontech Laboratories, Inc.).
Results presented using the ICELL8 Single-Cell system display the power of high... More